Amoxicillin/clavulanic Acid

Amoxicillin/clavulanic acid (INN) or co-amoxiclav (BAN) is a combination antibiotic consisting of amoxicillin trihydrate, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against amoxicillin-resistant bacteria that produce β-lactamase.

Unlike co-trimoxazole, the BAN has not been widely adopted internationally. Trade names include Augmentin (by GlaxoSmithKline), Enhancin/Mox Clav by Ranbaxy Labs Limited, Finemox CV by Finecure Pharmaceuticals Ltd, Clavamox (by Pfizer), and CLAMP (by Dr. Reddy's Laboratories).